Healthcare Analysing Sepsis Management Part I: Diagnosis

Recent Advances in Sepsis Diagnosis: PCR, Immunoassays, Sequencing and beyond

INDUSTRY
Healthcare

RELEASE DATE
22-Jun-2020
REGION
North America
DELIVERABLE TYPE
Technology Research

RESEARCH CODE
D995-01-00-00-00
SKU
HC03306-NA-TR_24516
Yes
SHARE

Analysing Sepsis Management Part I: Diagnosis
Published on: 22-Jun-2020 | SKU: HC03306-NA-TR_24516

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

Sepsis diagnosis

The current research study discusses the understanding of sepsis, its epidemiology, sepsis diagnosis and unmet clinical need of rapid sepsis diagnosis, existing and developing diagnostic platforms for sepsis management including patents landscape, clinical studies, Regional analysis, companies and their sepsis diagnostic platforms. 

The clinical studies part covers major sepsis diagnosis clinical trials from clinicaltrials.gov, their progress status, type of phase and industrial and non-industrial sponsors.

The sepsis diagnosis platforms discussed in this research study include existing and developing sepsis diagnostic platforms such as procalcitonin immunoassays, lateral flow immunoassays, Heparin Binding Protein (HBP) immunoassays, Complement C5a based immunoassays; nucleic acid sequencing directly from body fluids and identification of pathogens and/or antimicrobial profiling through Artificial Intelligence (AI) based technology; Novel technologies like blood cleaning system, Cell Mechanics, FISH (Fluorescence In-Situ Hybridization), Host-gene-expression-based approaches for sepsis diagnosis. 

A major part of the study talks about a variety of PCR and real-time PCR-based rapid diagnosis platforms for sepsis management. Some of these are direct sample-in/results-out and some platforms require few hours of blood incubation followed by sample-in/results-out. 

Additionally, this study discusses some of the instruments/ analysers and handheld devices, Mass-spectroscopy based sepsis diagnosis, Machine Learning and predictive algorithm for sepsis diagnosis and combination approaches. 

Further, this study profiles major players in sepsis diagnosis from North America, Europe and some players from Asia.

1.1 Research Scope: Sepsis Diagnosis

1.2 Analysis Framework: Frost & Sullivan Core Value

1.3 Research Methodology: Five Steps Toward Success

1.4 Key Findings of Technology Breakthrough Driving Sepsis Diagnosis

2.1 Research Scope: Current Status and Challenges of Sepsis Diagnosis

2.2 Types of Sepsis Diagnosis Tests

3.1 Fundamentals and Epidemiology of Sepsis

3.2 Unmet Needs in Sepsis Management

4.1 Outlook of Sepsis Diagnosis Clinical Trials

4.2 Industry Sponsored Sepsis-Diagnostic Test Clinical Trials

4.3 Non-industry Sponsored Sepsis-Diagnostic Test Clinical Trials in Europe

4.4 Non-industry Sponsored Sepsis-Diagnostic Test Clinical Trials in the Americas, Asia and Rest of the World

4.5 Scholarly Publications Including Patents for Sepsis

5.1 List of COMPANIES in Sepsis Diagnosis

5.2 The US Is The Biggest Hub For Sepsis Diagnosis

5.3 Procalcitonin-based Sepsis Diagnosis

5.4 Procalcitonin and Combination-based Sepsis Diagnosis Technologies

5.5 Sepsis Diagnosis Through Multiple Novel Immunoassays

5.6 Sequencing-based Detection of Sepsis Causing Pathogens

5.7 AI-Sequencing Platforms for Sepsis Causing Pathogen Detection

5.8 Machine Learning AND Host gene expression-based Platforms for sepsis diagnosis

5.9 Mass Spectroscopy-based Sepsis Diagnosis Platforms

5.10 Novel Platforms for Sepsis Diagnosis

5.11 Analyzers and Devices for Sepsis Diagnosis

5.12 Europe: PCR-based Sepsis Diagnosis Platforms

5.13 Americas: PCR-based Sepsis Diagnosis Platforms from big Companies

5.14 Americas: PCR-based Sepsis Diagnosis Platforms from mid-sized Companies

5.15 Americas: PCR-based Sepsis Diagnosis Platforms from small Companies

5.16 Asia: PCR-based Sepsis Diagnosis Platforms

5.17 Sepsis Diagnosis Tests under Development

5.18 Sepsis Diagnosis Companies with Revenue

6.1 Growth Opportunity 1: Selecting the Perfect Test for Specific Need

6.2 Growth Opportunity 2: Business Opportunities Beyond Diagnosis

7.1 Industry Interactions

Legal Disclaimer


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

15 Sep 2026   |   Global   |   Market Research

Vendor Profiles: Advanced Wound Care Management Market, Global, 2025

The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressu...

11 Sep 2026   |   Global   |   Frost Radar

Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2026

Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generati...

07 Sep 2026   |   Global   |   Technology Research

Synthetic Antibodies and AI-Optimized Immunotherapies

Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...

28 Aug 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...

27 Aug 2026   |   Global   |   Frost Radar

Frost Radar: AI-Powered Molecular Diagnostics, 2026

AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Sepsis diagnosis The current research study discusses the understanding of sepsis, its epidemiology, sepsis diagnosis and unmet clinical need of rapid sepsis diagnosis, existing and developing diagnostic platforms for sepsis management including patents landscape, clinical studies, Regional analysis, companies and their sepsis diagnostic platforms.  The clinical studies part covers major sepsis diagnosis clinical trials from clinicaltrials.gov, their progress status, type of phase and industrial and non-industrial sponsors. The sepsis diagnosis platforms discussed in this research study include existing and developing sepsis diagnostic platforms such as procalcitonin immunoassays, lateral flow immunoassays, Heparin Binding Protein (HBP) immunoassays, Complement C5a based immunoassays; nucleic acid sequencing directly from body fluids and identification of pathogens and/or antimicrobial profiling through Artificial Intelligence (AI) based technology; Novel technologies like blood cleaning system, Cell Mechanics, FISH (Fluorescence In-Situ Hybridization), Host-gene-expression-based approaches for sepsis diagnosis.  A major part of the study talks about a variety of PCR and real-time PCR-based rapid diagnosis platforms for sepsis management. Some of these are direct sample-in/results-out and some platforms require few hours of blood incubation followed by sample-in/results-out.  Additionally, this study discusses some of the instruments/ analysers and handheld devices, Mass-spectroscopy based sepsis diagnosis, Machine Learning and predictive algorithm for sepsis diagnosis and combination approaches.  Further, this study profiles major players in sepsis diagnosis from North America, Europe and some players from Asia.
More Information
Deliverable Type Technology Research
No Index No
Podcast No
Author Harshal Patil
Industries Healthcare
WIP Number D995-01-00-00-00
Is Prebook No

Analysing Sepsis Management Part I: Diagnosis

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC03306-NA-TR_24516